Biontech to close three German plants: 1,800 jobs lost

TVS News AI, editorially supervised, presents Biontech to close three German plants: 1,800 jobs lost.

The biotech company Biontech is closing three of its German plants. According to a report by Handelsblatt, around 1,800 employees in Idar-Oberstein, Marburg, and Tübingen will lose their jobs – the company has found no buyer for the sites.

According to Handelsblatt, Biontech is best known as a vaccine manufacturer. Now three sites in Germany are disappearing – with far-reaching consequences for the regions and the biotech industry.

What does the closure mean for employees?

All 1,800 positions at the three plants are facing elimination. Idar-Oberstein is in Rhineland-Palatinate, Marburg in Hesse, Tübingen in Baden-Württemberg. This makes the job cuts one of the larger contractions in Germany's biotech industry.

Why is Biontech facing criticism?

The news is drawing out a former competitor – and they are not only complaining about Biontech, but also about their own industry. Handelsblatt states verbatim:

All that state money is now lying on the scrapheap.

The accusation is directed not only at Biontech, but also at competitors. Who exactly is behind the statement can be read in the original Handelsblatt text.

What remains unclear so far

Handelsblatt has not yet reported in detail on the specific timeline of the plant closures, possible redundancy plans, or the future of individual facilities. What role state subsidies played in the site decisions also remains unclear in the available excerpt.

One thing is clear: three German sites are closing, 1,800 people are losing their jobs – and a former competitor is settling scores with Biontech and the broader industry.